Rhone-Poulenc Rorer S.A.
Records under this name other than patents Rhone-Poulenc Rorer S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Rhone-Poulenc Rorer S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE39,078 | Recombinant adenoviruses for gene therapy in cancers Formerly held Term ended Term ended Apr 25, 2023 · USPTO record | Term ended | Term ended Apr 25, 2023 | USPTO record |
| US 6,300,375 | Sodium oxamate for the treatment of diabetic conditions Term ended Term ended Dec 12, 2020 · USPTO record | Term ended | Term ended Dec 12, 2020 | USPTO record |
| US 6,316,422 | Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof Formerly held Term ended Term ended Nov 6, 2020 · USPTO record | Term ended | Term ended Nov 6, 2020 | USPTO record |
| US 8,835,618 | Mutations of the parkin gene Formerly held Term ended Term ended Sep 16, 2020 · High confidence | Term ended | Term ended Sep 16, 2020 | High confidence |
| US 6,410,298 | Adenovirus vectors and method for reducing homologous recombination phenomena Formerly held Term ended Term ended Sep 11, 2020 · USPTO record | Term ended | Term ended Sep 11, 2020 | USPTO record |
| US RE37,447 | Modified Kluyveromyces yeasts, their preparation and use Formerly held Term ended Term ended Aug 16, 2020 · USPTO record | Term ended | Term ended Aug 16, 2020 | USPTO record |
| US 6,596,880 | Method for preparing taxane derivatives Formerly held Term ended Term ended Jul 22, 2020 · USPTO record | Term ended | Term ended Jul 22, 2020 | USPTO record |
| US 6,242,603 | Process of preparing lysergic acid Formerly held Term ended Term ended Jun 21, 2020 · USPTO record | Term ended | Term ended Jun 21, 2020 | USPTO record |
| US 6,403,569 | Method for treating cancer using camptothecin derivatives and 5-fluorouracil Formerly held Term ended Term ended Apr 28, 2020 · USPTO record | Term ended | Term ended Apr 28, 2020 | USPTO record |
| US 6,528,315 | Method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor Formerly held Term ended Term ended Apr 22, 2020 · USPTO record | Term ended | Term ended Apr 22, 2020 | USPTO record |